Notice ID: c046b3ade89a4d3b8fbcb9fd9d78582fSolicitation
Therapeutic for treatment of Thrombocytopenia arising from H-ARS
Archived on September 24, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- August 16, 2022
- Notice type
- Solicitation
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75A50122R00021
- Notice ID
- c046b3ade89a4d3b8fbcb9fd9d78582f
Description
The objectives of this contract are: 1) to acquire a U.S. Food and Drug Administration (FDA) approved treatment for use in a mass casualty event where thrombocytopenia or platelet loss is a major concern. The total procurement may be up to 170,000 unit doses. The initial procurement shall be up to 51,000 doses. In each option period additional pharmaceutical doses shall be procured to reach the 170,000 level. The product selected will be procured in stages (i.e., initial purchase of up to 51,000 unit doses, plus up to five additional potential deliveries all over a 10-year period to build towards the requirement need-based quantity); and 2) for the Contractor to provide, as part of the annualized acquisition, a contractor-managed inventory (e.g., VMI) with rotation of stock to control product expiry. The inventory management plan shall also include a plan to provide the SNS with an accurate inventory of product as well as location(s) should the U.S. Government (USG) have an immediate need for product in an emergency situation. The Contractor's plan to deliver the product as needed by the government, the Quality Agreement with the Assistant Secretary of Preparedness and Response (ASPR), shall be negotiated to align with the USGs specific product use during a mass casualty event. In order to meet the above objectives, the Contractor shall have evidence that the labeling, storage, distribution and transport programs are secure and controlled.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75A50122R00021- Pre-Solicitation
- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- Pre-SolicitationJun 15, 2022
Therapeutic for treatment of Thrombocytopenia arising from H-ARS
- 4×SolicitationCurrentJul 26, 2022
Therapeutic for treatment of Thrombocytopenia arising from H-ARS
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50122R00021
Archive Date
Sep 24, 2022
Office Address
WASHINGTON, DC, 20515